Table 2.
Antibody Combinations | Group | +/− (%) | +/+ (%) | -/+ (%) |
---|---|---|---|---|
CD4/CD8 | VHM | 10.03 ± 1.27 | 2.03 ± 0.51 | 13.02 ± 0.67 |
300 | 9.60 ± 0.44 | 1.56 ± 0.31 | 12.94 ± 1.45 | |
CD4/CD25 | VHM | 10.56 ± 0.81 | 1.19 ± 0.09 | 1.24 ± 0.29 |
300 | 9.85 ± 0.65 | 1.03 ± 0.10 | 1.12 ± 0.30 | |
CD8/CD25 | VHM | 8.44 ± 0.48 | 0.60 ± 0.11 | 1.67 ± 0.19 |
300 | 8.89 ± 1.73 | 0.53 ± 0.08 | 1.47 ± 0.32 | |
CD24/CD5 | VHM | 66.40 ± 1.93 | 2.17 ± 0.10 | 23.00 ± 1.56 |
300 | 65.94 ± 2.33 | 2.25 ± 0.39 | 24.44 ± 2.37 | |
CD40/CD44 | VHM | 18.74 ± 0.89 | 2.20 ± 0.27 | 3.12 ± 0.21 |
300 | 16.83 ± 1.43 | 1.77 ± 0.15 | 2.95 ± 0.26 | |
B220/CD40L | VHM | 15.64 ±1.25 | 0.86 ±0.08 | 3.14±0.15 |
300 | 12.09 ±1.58 | 0.71 ±0.11 | 3.13±0.26 |
* p < 0.05 as compared to the vehicle male (VHM) control group. The values are presented as mean ± SEM. *, p < 0.05. N = 4–5. VHM, vehicle males.